cagrilintide semaglutide cagrisema phase 3 results 2024 2025 Incretin-based therapies for the treatment of obesity-related diseases CagriSema Reduces Blood Pressure in

From payer friction to behavioral drop-off, GLP-1s are challenging pharma to rethink how success is measured in the obesity and diabetes markets

Food and Drug Administration (FDA) is the primary regulatory body in the United States responsible for ensuring the safety, efficacy, and quality of medical products

Three very different formulas

Novos development chief had told investors last year that if Novo were to start its own work in alcoholism, it would probably use cagrisema, not its blockbuster semaglutide.

While gallbladder surgery is safe and there are no specific dietary limitations, there are certain drinks you should avoid to minimize GI upset

Inspira Health offers personalized guidance to help you find the right GLP-1 option for your goals and lifestyle.